Shanghai, China – On March 29, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") was awarded the Top 20 Outstanding Contributors to Advanced Manufacturing Industry of Shanghai Pudong New Area during the "2016 Awarding Ceremony of Outstanding Contributor to Economic Growth of Pudong New Area," fully demonstrating government authority's recognition of the achievements MicroPort® made in 2016.

Weng Zuliang, Secretary of Pudong District Committee of the CPC, said in the report of the Fourth National Party Congress that Pudong is "dedicated to creating the world's most attractive investment destination." To meet that goal, Pudong aims to create a friendly, safe and attractive business environment to encourage industry leaders to take root in Pudong and help them to grow stronger. Thus, the district government held the "2016 Awarding Ceremony of Outstanding Contributors to Economic Growth of Pudong New Area" as a way to enhance communications with key enterprises. During the ceremony, a total of 140 enterprises were given seven awards including Top 20 Special Contributors to Economic Growth, Top 20 Outstanding Contributors to Financial Industry, Top 20 Outstanding Contributors to Advanced Manufacturing Industry, Top 20 Outstanding Contributors to Modern Service Industry, Top 20 Outstanding Contributors to Technology Innovation, Top 20 Innovative Enterprises, and Top 20 High-growth Enterprises. These 140 enterprises paid RMB96.7 billion in taxes in 2016, accounting for one third of the total tax income of Pudong District.

Manufacturing is an important sector of the national economy. The high-performance medical device industry which MicroPort® is dedicated to belongs to the advanced manufacturing industry that has been included in the ten key development areas of "Made in China 2025." In 2016, MicroPort® actively captured the upside potentials brought by the government policies and mechanism reform, and achieved a remarkable success with significant revenue increase in several business segments through advancing R&D processes, optimizing sales channels, developing in emerging markets, integrating advantageous resources and improving operating efficiencies.

Dr. Zhaohua Chang, MicroPort® Chairman and Chief Executive Officer, stated, "In 2017, we will continue to take solid steps on the path towards becoming a leading global medical device company with sound operating strategies, advanced and diversified product pipeline, as well as further improved corporate governance."